Condensed Consolidated Statements of Cash Flows - Unaudited - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015
Cash flows from operating activities:
Net income (loss)	$ (1,972)	$ 17,313
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	67,414	26,941
Debt related amortization included in interest expense	5,387	5,368
Stock-based compensation	7,179	9,044
Other non-cash losses (gains), net	1,938	(1,549)
Deferred income taxes	(12,519)	(3,614)
Changes in operating assets and liabilities:
Accounts receivable	12,510	17,395
Inventories	(10,010)	(34,992)
Prepaid expenses and other current assets	(4,663)	(1,371)
Accounts payable	4,885	3,347
Accrued expenses	(5,650)	(5,823)
Income taxes	7,300	(1,074)
Net cash provided by operating activities	71,799	30,985
Cash flows from investing activities:
Acquisition of property, plant and equipment	(46,968)	(31,307)
Purchase of cost and equity method investments, net	(2,917)	(6,300)
Other investing activities	(1,000)	732
Net cash used in investing activities	(50,885)	(36,875)
Cash flows from financing activities:
Principal payments of long-term debt	(28,750)	(7,500)
Proceeds from issuance of long-term debt	57,000	0
Issuance of common stock	723	5,988
Payment of debt issuance costs	(781)	0
Distribution of cash and cash equivalents to Nuvectra Corporation	(76,256)	0
Purchase of non-controlling interests	(6,818)	0
Other financing activities	(3,983)	(318)
Net cash used in financing activities	(58,865)	(1,830)
Effect of foreign currency exchange rates on cash and cash equivalents	468	(510)
Net decrease in cash and cash equivalents	(37,483)	(8,230)
Cash and cash equivalents, beginning of period	82,478	76,824
Cash and cash equivalents, end of period	$ 44,995	$ 68,594